Molecular therapies for cancer represent a cutting-edge frontier in oncological treatment, promising innovative and targeted solutions for battling malignancies.Recent studies published by Harvard's Department of Chemistry and Chemical Biology have harnessed intricate insights around molecular glues and genetic mutations to affect critical protein interactions in cancer cells.